IMVT
Immunovant, Inc. · Healthcare
Chief Technology Officer Jay S Stout sold $138K of Immunovant, Inc.
Sold$137,925
$39.55Price
3,487Shares
−2%Stake
What IMVT did after the filing
- The stock from Mon, Jul 13 open, $39.24
- +10.9%
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Aug 25 close.
Traded Wed, Jul 8. Filed Fri, Jul 10, 4:12 PM ET, after the close. Returns use the Jul 13 open and the Aug 25 close. Not investment advice.